DAIHAN Scientific Q1 2026: Dividend Increase and Solid Financials

Consolidated Q1 2026 revenue: 17.595bn KRW (operating profit 0.973bn, net income controlling 0.549bn), stable year-over-year
Final dividend for FY2025: 125 won per share (vs 60 won prior year, +108%), strengthening shareholder returns
Sold entire stake in subsidiary Daehan Analysis Equipment, recording a disposal loss of 0.113bn KRW
Debt ratio 25.5%, short-term borrowings 0.434bn, cash equivalents 3.536bn; sound financial position
R&D expenditure 0.266bn KRW (1.51% of sales), continuous investment
No change in treasury shares (holding 594,818 shares, 7.98% ownership)